Sartorius is pleased to connect with the Sid Martin community to discuss how their expertise, technologies, and application support can help advance stem cell, immune cell, and other advanced-therapy workflows.

Sartorius supports academic innovators and early-stage biotechnology companies as they move promising research toward scalable, reproducible processes. Their portfolio includes solutions for cell culture, cell and gene therapy development, bioprocessing, analytical workflows, and laboratory applications. They work collaboratively with researchers and emerging biotech teams to help address evolving needs from early research and process development through scale-up and manufacturing readiness.